Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-7264 for endometriosis-related pain
2018-001098-26Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefapixant in endometriosis, sponsored by Merck & Co.. Started Jul 2018; status: completed.
02
Drugs
gefapixant
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2018-001098-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001098-26.